Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5.
about
Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?STAT5 in hematopoietic stem cell biology and transplantationSTAT5-regulated microRNA-193b controls haematopoietic stem and progenitor cell expansion by modulating cytokine receptor signalling.Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5ADynamic ligand modulation of EPO receptor pools, and dysregulation by polycythemia-associated EPOR allelesDisruption of Notch signaling aggravates irradiation-induced bone marrow injury, which is ameliorated by a soluble Dll1 ligand through Csf2rb2 upregulationG-CSFR ubiquitination critically regulates myeloid cell survival and proliferation.Calcineurin/Nfatc1 signaling links skin stem cell quiescence to hormonal signaling during pregnancy and lactationCSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness.Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progressionA truncation mutant of Csf3r cooperates with PML-RARα to induce acute myeloid leukemia in mice.Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer.ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiologyInterpretation of cytokine signaling through the transcription factors STAT5A and STAT5BGenetic and molecular diagnosis of severe congenital neutropenia.Arteriolar niches maintain haematopoietic stem cell quiescence.An activating mutation in the CSF3R gene induces a hereditary chronic neutrophilia.Hematopoietic stem cell transplantation for severe congenital neutropenia.Regulation of hematopoietic stem cell activity by inflammation.Granulocyte colony-stimulating factor receptor mutations in myeloid malignancy.A Truncated Granulocyte Colony-stimulating Factor Receptor (G-CSFR) Inhibits Apoptosis Induced by Neutrophil Elastase G185R Mutant: IMPLICATION FOR UNDERSTANDING CSF3R GENE MUTATIONS IN SEVERE CONGENITAL NEUTROPENIA.Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies.Severe congenital neutropenias.Unpaired Extracellular Cysteine Mutations of CSF3R Mediate Gain or Loss of Function.Bortezomib inhibits STAT5-dependent degradation of LEF-1, inducing granulocytic differentiation in congenital neutropenia CD34(+) cellsSevere congenital neutropenia and chronic neutrophilic leukemia: an intriguing molecular connection unveiled by oncogenic mutations in CSF3R.Discovering early molecular determinants of leukemogenesis.Chronic neutrophilic leukemia: new science and new diagnostic criteria.Gain-of-function mutations in granulocyte colony-stimulating factor receptor (CSF3R) reveal distinct mechanisms of CSF3R activation.
P2860
Q26828777-238F11A6-9C57-44AE-80F0-8C70137E6202Q27022428-F881944F-BCA7-40F9-AB42-58609FD0B747Q27317710-D5991565-CD0A-4E87-B56B-C3BC5984051FQ28585680-57864CE4-A980-42CD-B80F-290120F82326Q28732847-57744AEA-00F0-488D-80D0-532FA4A3267AQ28834064-BFED6A75-AED1-4386-A293-28D9FFA8461AQ33377020-B3817290-86CF-49AA-A1C7-650831DE2C28Q33600250-1500172F-0505-4B1D-8A07-72536CBC9207Q33909621-B0A39EF2-E47F-470A-BDEB-0EF5AF3D68C5Q34027499-519540E4-8B72-4D62-990B-5E0B336F5E69Q34755408-2BCBF4F1-0BD2-49D7-BD9A-94B09D660790Q35564931-64A8E42F-0940-4DD8-B3ED-F46DAE5331C7Q35683515-3558D9FE-EDE6-4647-BB3A-DD0E1FD6765BQ36573828-9BF31ADA-9738-4A90-8D1D-97B857B77EA7Q36672274-FA004A59-3638-456C-AF0C-D00A48EF36FBQ37287780-52662606-87D4-4AFF-8414-240C5F7AFB6DQ37292035-1318454F-1210-4396-B716-C1BDCD316BDAQ37292779-BA6EDA41-FE4E-47DD-8DB2-542DC1A3748AQ37955726-BB0011CF-D532-43A4-AF8B-1283C2073898Q38123812-47591670-4CA7-4362-A162-B6775D79CD17Q38211431-931CF362-9C26-4FBE-91CD-1E390C128DF9Q38722029-FAA0099A-9607-46BA-BB38-D3A337E8F10FQ38993081-788B7833-5C4F-4E77-8F75-4C5C3143F4AAQ39359222-B78A03AF-FB92-476D-B62A-3E1A04669612Q40144730-5A495B84-EA29-41AC-9B2A-F99D0008BA59Q42061078-C86716CC-434D-4DB3-95E9-874C4393D259Q42958779-84A55E76-5942-4838-839C-08CCFF701891Q43053063-850D92AF-93C4-4D9D-8AD8-7DAFF27E4F50Q49239291-AC9A1E15-EC0A-48F7-8D3D-CE170CF6244AQ52639451-C0E3521A-3936-4F1F-8778-B6D5C34C3A01
P2860
Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5.
@ast
Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5.
@en
type
label
Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5.
@ast
Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5.
@en
prefLabel
Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5.
@ast
Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5.
@en
P2093
P2860
P356
P1476
Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5
@en
P2093
Daniel C Link
Ghada Kunter
Jennifer A Cain
Maxwell M Krem
Michael H Tomasson
William C Eades
P2860
P304
P356
10.1172/JCI32704
P407
P577
2008-03-01T00:00:00Z